Gonal F

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

InfertilityAnovulation

121 competitors in Infertility

#DrugCompanyPhaseTrials

1

Victoza

Novo Nordisk

Phase 3

12

Voltaren

Novartis

Phase 3

13

Depo-Provera

Eli Lilly

Phase 3

—4

Activella

Eli Lilly

Phase 3

—5

Zoladex

AstraZeneca

Phase 3

—6

Gonal-F

EMD Serono

Phase 3

37

Alli

EEngelhard Arzneimittel GmbH & Co.KG

Phase 3

18

Prograf

VVeloxis Pharmaceuticals

Phase 3

19

Human Chorionic Gonadotropin

Merck & Co.

Phase 3

210

Estradiol Valerate

Bayer

Phase 3

1Show 31 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Ovarian Stimulation4 trials

Synchronization of Follicle Wave Emergence and Ovarian Stimulation

Completed·UUniversity of Saskatchewan·Phase 4·NCT00439829·80 enrolled

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Terminated·Merck & Co.·Phase 3·NCT01497197·174 enrolled

NATural Ovarian Stimulation

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT02892942·129 enrolled

Show 1 more trial

Assessment of the Role of Serum FSH Monitoring During Ovarian Stimulation and Identification of an Optimal Range for Expected Normal Responders

Recruiting·AART Fertility Clinics LLC··NCT06572930·150 enrolled

Assisted Reproductive Technology3 trials

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)

Completed·Merck & Co.·Phase 3·NCT02047227·939 enrolled

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

Completed·Merck & Co.·Phase 3·NCT01183143·215 enrolled

CONSORT Randomized Controlled Trial in Assisted Reproductive Technology

Completed·Merck & Co.·Phase 4·NCT00829244·200 enrolled

Treatment2 trials

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

Completed·Merck & Co.·Phase 3·NCT01297465·202 enrolled

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Completed·Ferring·Phase 2·NCT01426386·265 enrolled

Women2 trials

Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women

Completed·Merck & Co.·Phase 1·NCT02592031·49 enrolled

Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women

Unknown status·AAlphamab Jilin Co., Ltd.·Phase 1·NCT03535103·32 enrolled

Efficacy and Safety2 trials

A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

Completed·DDong-A ST Co., Ltd.·Phase 3·NCT01820728·93 enrolled

Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

Completed·Qilu Pharmaceutical Co., Ltd.·Phase 3·NCT05149924·354 enrolled

12 more indications

Tics1 trial

Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application

Completed·PPolymun Scientific GmbH·Phase 1·NCT01141270·32 enrolled

Polycystic Ovarian Syndrome (PCOS)1 trial

A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation

Completed·Merck & Co.··NCT02607293·1,064 enrolled

Anovulation1 trial

Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation

Completed·Changchun GeneScience Pharmaceutical Co., Ltd.·Phase 3·NCT02335879·534 enrolled

Female1 trial

Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers

Active, not recruiting·Qilu Pharmaceutical Co., Ltd.·Phase 1·NCT06864793·48 enrolled

In Vitro Fertilization (IVF)1 trial

Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)

Completed·Merck & Co.·Phase 4·NCT00249834·166 enrolled

Ovulation Induction1 trial

Low-dose Gonal-f® in Ovulation Induction

Terminated·Merck & Co.·Phase 4·NCT01871532·24 enrolled

Efficacy1 trial

Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF

Completed·IIBSA Institut Biochimique SA·Phase 3·NCT00378001·152 enrolled

Ovarian1 trial

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China

Completed·Ferring·Phase 3·NCT06173869·301 enrolled

Infertility1 trial

A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART

Completed·GGema Biotech S.A.·Phase 3·NCT02454556·106 enrolled

Single Dose1 trial

Single Dose FSH-GEX™ in Healthy Volunteers

Completed·GGlycotope GmbH·Phase 1·NCT01354886·19 enrolled

Clinical Trial1 trial

Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30

Completed·WWest China Second University Hospital·Phase 1·NCT06778304·48 enrolled

Unspecified1 trial

Pergoveris FD and Liquid China BE Study

Completed·Merck & Co.·Phase 1·NCT04899193·72 enrolled

Details

Drug Info

Related News